1. Home
  2. VLN vs STRO Comparison

VLN vs STRO Comparison

Compare VLN & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valens Semiconductor Ltd.

VLN

Valens Semiconductor Ltd.

HOLD

Current Price

$1.56

Market Cap

206.8M

Sector

Technology

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$9.36

Market Cap

181.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLN
STRO
Founded
2006
2003
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.8M
181.4M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
VLN
STRO
Price
$1.56
$9.36
Analyst Decision
Buy
Strong Buy
Analyst Count
2
14
Target Price
$4.00
★ $47.23
AVG Volume (30 Days)
★ 430.4K
271.7K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $38,419,000.00
Revenue This Year
$11.20
N/A
Revenue Next Year
$18.46
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.10
$0.72
52 Week High
$3.71
$43.85

Technical Indicators

Market Signals
Indicator
VLN
STRO
Relative Strength Index (RSI) 40.10 22.90
Support Level $1.43 N/A
Resistance Level $1.63 $16.99
Average True Range (ATR) 0.09 1.23
MACD -0.02 -0.15
Stochastic Oscillator 24.18 2.70

Price Performance

Historical Comparison
VLN
STRO

About VLN Valens Semiconductor Ltd.

Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Cross Industry Business, which includes solutions for the non-automotive verticals, including audio-video, industrial, machine vision and medical markets, that deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: